To print: Select File and then Print from your browser's menu

Title: Sertraline Treats Psychic Anxiety Symptoms Associated with a Range of Depressive and Anxiety Disorders: Presented at ADAA

"Sertraline Treats Psychic Anxiety Symptoms Associated with a Range of Depressive and Anxiety Disorders: Presented at ADAA"

By Alison Palkhivala TORONTO, ON -- April 1, 2003 -- Psychic symptoms of anxiety, which are a common feature of both anxiety and depressive disorders, are generally responsive to sertraline therapy, according to analysis of data from nine double-blind studies. Larry Culpepper, MD, Boston University Medical Center, Boston, Massachusetts, and colleagues combined data across double-blind studies on the use of sertraline in depressive and anxiety disorders. These studies included four on panic disorder, two on post-traumatic stress disorder, one on social anxiety disorder, one on generalized anxiety disorder and one on major depressive disorder. The findings were presented here in a poster on March 29th at the 23rd Annual Conference of the Anxiety Disorders Association of America. Based on Hamilton Anxiety Scale (Ham-A) scores, mean baseline psychic anxiety scores were highest for patients with generalized anxiety disorder (25/13.7), panic disorder (23/11.6) and major depressive disorder (16/10.8). They were lowest among patients with post-traumatic stress disorder (20/13.4) and social anxiety disorder (10/6.4). Results also showed that psychic anxiety symptoms contributed to a larger proportion of the baseline Ham-A total score in major depressive disorder (68%) and generalized anxiety disorder (56%), compared with the other disorders. Treatment with sertraline resulted in significant improvement in the Ham-A total score compared with placebo in patients with panic disorder (P=0.005), social anxiety disorder (P=0.041) and generalized anxiety disorder (P=0.0001). However, it did not provide this benefit in patients with post-traumatic stress disorder. The analysis involved researchers from Pfizer, Inc., manufacturers of sertraline. [Study title: Generalized and Psychic Anxiety Symptoms: Cross-disorder Prevalence and Responsivity to Sertraline Treatment. Abstract 12]

Copyright © 2009 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content.